Monosaccaridi

2-Keto-L-galactonic acid is a chemical compound that belongs to the group of fatty acids. It is produced by the degradation of polyunsaturated fatty acids and has been shown to be a potential control agent for hepatic steatosis. 2-Keto-L-galactonic acid also inhibits the synthesis of dinucleotide phosphate in rat liver cells, leading to an accumulation of intracellular potassium ion. This compound inhibits the uptake of glucose by activating ATPase, which leads to an increase in intracellular pH. The uptake of 2-keto-L-galactonic acid into cells has been shown using cell culture experiments with wild type and mutant strains.

Ouabain is a potent inhibitor of the Na+/K+-ATPase pump in cardiac and skeletal muscles. It has been shown to inhibit signal pathways that are involved in the regulation of cellular membrane potentials, such as the michaelis–menten kinetics. Ouabain has also been found to be effective against syncytial virus infection. Ouabain inhibits viral replication by inhibiting cellular protein synthesis and reducing cell number due to its cytotoxic effects on myocardial cells. Ouabain has also been found to inhibit neuronal death induced by α1-adrenergic receptor agonists, such as p2y receptors.

3,4-O-Isopropylidene-b-D-arabinopyranose is a synthetic monosaccharide that is used in the synthesis of oligosaccharides and polysaccharides. It can be fluorinated, methylated, or glycosylated to produce a range of compounds with different properties. 3,4-O-Isopropylidene-b-D-arabinopyranose is not active against bacteria, but it does inhibit the growth of yeast cells. In addition to its use in biochemistry and as a nutritional supplement for animals and humans, 3,4-O-Isopropylidene-b-D-arabinopyranose can be used as an additive for plastics and other materials.

Benzyl 4-C-nitromethyl-b-D-arabinopyranoside is a synthetic glycosylation agent that is used in the synthesis of complex carbohydrates. It has been shown to react with methyl, fluorine, and saccharide groups. This product can be modified to include a wide range of saccharides, including monosaccharides, disaccharides, and polysaccharides. Benzyl 4-C-nitromethyl-b-D-arabinopyranoside is also available in custom synthesis and high purity.

L-altronojirimycin is a diterpene glycoside that belongs to the group of natural products that have inhibitory properties against lipid peroxidation. It has been shown to decrease the concentration of 1,2-dipalmitoylglycerophosphocholine (DPPC) in primary cells and reduce the rate of lipid peroxidation in a concentration-dependent manner. L-altronojirimycin inhibits the activity of enzymes such as acetylcholinesterase and phospholipase A2, which are involved in inflammation. This drug has also been shown to have cardioprotective effects and inhibit mutations in cardiac muscle cells. L-altronojirimycin has been tested for its long-term efficacy and shown to be effective against both bowel disease and cardiac effects.

Glcnacβ(1-3)GalNAc-α-Thr is a polysaccharide that is found in the human body, which is a complex carbohydrate. It is an oligosaccharide modification of galactose and alpha-threonine. Glcnacβ(1-3)GalNAc-α-Thr can be custom synthesized to order with high purity and monosaccharide content. This product is used for research purposes and has not been approved for therapeutic use. The CAS number for this compound is 286959-52-2.

2-Amino-2-deoxy-D-idose is a sugar that is found in the cell walls of bacteria. It has been shown to be an inhibitor of the enzymes that catalyze the acetylation and methylenecyclopropanes reactions, which are necessary for bacterial growth. 2-Amino-2-deoxy-D-idose binds to copper ions, preventing them from binding with the enzymes. This drug also chelates metals such as zinc, iron, and manganese to prevent their use by bacteria.

2-Hydroxyimipramine b-D-glucuronide is a custom synthesis, modification, and fluorination of the drug 2-hydroxyimipramine. The methyl group from the molecule is replaced with a fluoro group. This modification leads to a new compound with improved pharmacokinetic properties. The new compound also has glycosylation sites on the sugar ring that are not present in the parent drug. This modification may lead to an increase in the therapeutic efficacy of 2-hydroxyimipramine b-D-glucuronide as it interacts with other drugs and increases their bioavailability.

4-Epi-daunosamine is a glycopeptide antibiotic that is used to treat infections caused by Gram-positive bacteria. It binds to the cell wall of these bacteria and inhibits the synthesis of new cell walls. This causes the cells to burst and die, which leads to bacterial death. 4-Epi-daunosamine has been shown to be effective against animal pathogens such as Streptococcus pneumoniae, Haemophilus influenzae, and Clostridium perfringens. 4-Epi-daunosamine also has a low level of toxicity in humans, but can cause adverse effects such as nausea and vomiting if taken in large doses.

Glucose pentaacetate is a form of glucose that reacts with boron trifluoride etherate to produce anomers. This process can be used to synthesize the anomeric form of glucose, which is important for the biosynthesis of glycosides. Glucose pentaacetate has been shown to react with nitrate and trifluoride, forming conjugates with aluminum and chloride. The catalytic stereocontrol of this reaction allows for the production of disaccharides without hydrogen chloride or formylation.

2,3,4-Tri-O-acetyl-1-azido-1-deoxy-b-D-arabinopyranosyl cyanide is a synthetic carbohydrate that can be modified with fluorination, methylation and glycosylation. It is modified with acetyl groups at the 2, 3 and 4 positions of the sugar ring. This carbohydrate has been used to synthesize oligosaccharides and polysaccharides. The modification of this carbohydrate has been shown to improve its solubility in water.

Benzyl 2-azido-2-deoxy-a-D-galactopyranoside (α-OBn GalN3) is a compound based on the structural features of α-OBn GalNAc. It features an azide functionality at C2 instead of the N-acetyl. α-OBn GalN3 inhibits glycosyltransferases responsible for O-GalNAc-type glycosylation and induces apoptosis in PC/AA/C1/SB10C and HCA7/C29 cells. The compound was tested at 0.5 mM for 4 days with different colorectal cell lines and showed an inhibition of cell growth. α-OBn GalN3 was also used as an intermediate for the total synthesis of (+)-Neocarzinostatin chromophore.

5-Deoxy-1,2-O-isopropylidene-5-(3-phenylpiperizin-1-yl)-a-D-xylofuranose is a methylated and fluorinated sugar that was synthesized by the click reaction. The synthesis of this compound required the use of an oligosaccharide coupled with a polysaccharide for the attachment of the piperazine moiety. This product has been shown to be stable in water and other solvents. 5DIOXFURANOSE is a white to off white crystalline powder that appears as needle crystals. It is soluble in water, methanol, ethanol, acetonitrile, acetone and chloroform.

Methyl 2,3-di-O-benzoyl-4,6-O-benzylidene-b-D-glucopyranoside is a carbohydrate with a saccharide structure that has been modified by fluorination and methylation. The sugar is an oligosaccharide containing sugar monomers of glucose and galactose. This compound is available for custom synthesis to order. It can be synthesized in high purity and with a high degree of modification, such as glycosylation, click modification, and methylation.

1,2,3,4,6-Penta-O-acetyl-a-D-thiogalactopyranose is a fluorinated saccharide that can be used as a research tool. It has been modified with methylation and glycosylation. This product is purified and custom synthesized to meet customer specifications.

6-O-Benzoyl-3-O-tert-butyldiphenylsilyl-D-galactal is an oligosaccharide with a complex carbohydrate structure. It is prepared by the modification of D-galactal with benzoyl chloride and subsequent reaction with tert-butyl diphosphite. This compound has been shown to have antihypertensive properties and to inhibit the growth of tumor cells in culture. 6-O-Benzoyl-3-O-tert butyldiphenylsilyl D galactal is a fluorinated, high purity, synthetic sugar that is effective for inhibiting tumor growth in culture.